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In vivooptical imaginghas emergedas apowerful toolwithwhich to study cellular responses to injuryanddisease in themammalianCNS.
Important new insights have emerged regarding axonal degeneration and regeneration, glial responses andneuroinflammation, changes
in the neurovascular unit, and, more recently, neural transplantations. Accompanying a 2017 SfN Mini-Symposium, here, we discuss
selected recent advances in understanding theneuronal, glial, andother cellular responses toCNS injury anddiseasewith in vivo imaging
of the rodent brain or spinal cord. We anticipate that in vivo optical imaging will continue to be at the forefront of breakthrough
discoveries of fundamental mechanisms and therapies for CNS injury and disease.
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Introduction
Understanding themulticellular response to injury and disease in
the mammalian CNS provides a foundation for the development
of therapeutic strategies for a variety of neurological conditions.
Studies with animal models rely heavily on histological analyses
of terminal samples as obligatory outcome measures. In vivo
optical imaging provides an alternative and complementary ap-
proach to investigating the molecular, cellular, and physiological
events after CNS injury and disease (Misgeld and Kerschensteiner,
2006). Advanced optical imaging technologies such as multipho-
ton microscopy (Denk et al., 1990) offer certain advantages over
wide-field fluorescencemicroscopy, including deeper tissue pen-
etration and less phototoxicity, which are conducive to repeated
in vivo imaging.
In the past several years, there has been a critical mass in
discoveries made with in vivo optical imaging in the injured or
diseased CNS. Insights on neuronal, glial, and other cellular re-
sponses have been reported that were not previously possible or
practical to obtain with endpoint analyses using conventional
histological methods. Time-lapse imaging of the same cellular
and subcellular structures depicts the dynamic responses to in-
jury and disease at a high spatiotemporal resolution. Imaging at
both the acute and chronic time points reveals unanticipated new
principles and mechanisms. The time is ripe to have a productive
and stimulating discussion on this topic so that the neuroscience
communitymay better capitalize on the power of in vivo imaging to
study the injured or diseased CNS.
At the 2017 Society for Neuroscience meeting, we will present
selected recent advances in using in vivo optical imaging to un-
derstand the multicellular responses to CNS injury and disease
(Mini-Symposium: In vivo Imaging of CNS Injury and Disease).
Here, we highlight some of these advances, giving consideration
to both theMini-Symposium (topics illustrated in Fig. 1) and the
published literature.
In vivo imaging provides unique insights into the axonal
responses to minimal injury in the CNS
CNS injuries associated with axon damage are without a cure and
often result in severe and permanent disability largely due to the
regeneration failure of injured axons (Chen and Zheng, 2014;
Geoffroy and Zheng, 2014). In vivo imaging of axonal dynamics
in the lesioned CNS is therefore an especially interesting area of
investigation because it can potentially inform strategies to pro-
mote functional circuit repair after spinal cord and brain injury.
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Kerschensteiner et al. (2005) were the first group to demonstrate
the utility of in vivo imaging of axonal response to injury in the
mammalianCNS.Usingwide-field fluorescencemicroscopy, this
study examined the degeneration and regeneration of Thy1-XFP-
labeled dorsal column sensory axons (Feng et al., 2000) after a
small pinprick injury in the mouse spinal cord. This led to the
identification of an acute phase of bidirectional axon degenera-
tion, which differs from the well characterized Wallerian degen-
eration that occurs distal to the injury site at a later phase
(Kerschensteiner et al., 2005).
Since then, spinal cord in vivo imaging has been used to char-
acterize the effect of microtubule stabilization on retraction bulb
formation after injury (Ertu¨rk et al., 2007), to demonstrate the
sustained responsiveness of a chronically injured dorsal column
sensory axon to a conditioning peripheral lesion (Ylera et al.,
2009), to investigate axon–blood vessel
interaction in regeneration and neuroin-
flammatory disease (Dray et al., 2009;
Davalos et al., 2012), to illustrate rapid
immobilization of regenerating sensory
axons after entering the dorsal root entry
zone following a dorsal root crush (Di
Maio et al., 2011), to reveal a phase-
specific role for STAT3 in initiating but
not sustaining sensory axon regeneration
(Bareyre et al., 2011), and to identify a role
of axon–macrophage interaction in sub-
acute axon degeneration after injury (Ev-
ans et al., 2014).
Buildingonan in vivo two-photon imag-
ingmethod in themouse spinal cord devel-
oped by Davalos et al. (2008), Lorenzana et
al. (2015) examined the effect of laser-
axotomizing a dorsal column sensory
axon just before or after a major branch
point. They found that axotomy just
proximal to the branch point leads to ax-
onal responses similar to axotomy of an
unbranched axon, as illustrated in current
neuroscience textbooks. However, when
axotomy occurs just distal to the branch
point, one branch was practically elimi-
nated by both retrograde and anterograde
degeneration, whereas the other branch,
still connected to the cell body via the
branch point, was typically protected from
destruction (Lorenzana et al., 2015). This
study illustrates that the axonal branch
may serve as a barrier for retrograde de-
generation and that a remaining axonal
branch stabilizes remaining axon archi-
tecture after axotomy to the other branch
(presented by B. Zheng, 2017 SfN Mini-
Symposium). It makes economical sense
for neurons to protect whatever synaptic
function there is left and to only to at-
tempt to regenerate when all or most syn-
aptic outputs have been lost. The exact
mechanisms through which neurons ac-
complish this remain to be investigated.
Meanwhile, this study illustrated dynamic
degeneration, regeneration, pruning, and
remodeling of dorsal column sensory ax-
ons up to 6 months after the initial axotomy.
Relatively less is known about the responses of axons in the
injuredmammalian brain, where axons can reach total lengths of
several tens of centimeters and have extremely elaborate branch-
ing patterns to connect to all of their targets. De Paola and col-
leagues used in vivo two-photon imaging and laser axotomy to
illustrate a high level of heterogeneity in the injury response of
cortical axons (Canty et al., 2013b). That study focused on the
behavior of individual axons in the adult cortical gray matter, a
fiber system vulnerable in many degenerative brain disorders.
Although some axon types exhibited a low level of regeneration
after laser axotomy, others (especially from layer 6 neurons) ex-
hibited a high level of axon regeneration associated with the
reestablishment of normal synaptic density. When they did re-
generate, these axons exhibited dynamic changes up to 6 months
Figure 1. In vivo imaging of CNS injury and disease. In vivo imaging of the brain and spinal cord has revolutionized our
understanding of CNS pathology including axonal, vascular, and immune responses to CNS injury and disease. Topics illustrated
here will be presented at a 2017 SfNMini-Symposium. Top row, Tracing of living severedmouse serotonin axons in the neocortex
(Jin et al., 2016), structural and functional in vivo imaging of transplanted human iPSC (hiPSC)-derived neurons expressing
TdTomato (red) and GCaMP6 (green) (Real and De Paola, unpublished data), calcium imaging of visual response in retinal axons
(Liang et al., unpublished data) are representative examples of imaging the dynamic responses of neuronal cells in the brain.
Bottom row, Imaging the spinal cord after contusion injury (axons in white, cell death marker dye in magenta; Williams et al.,
2014), injury response of axonal branches after laser axotomy (Lorenzana et al., 2015), andBBBdisruption andmicroglia responses
in autoimmune neuroinflammation (Davalos et al., 2012) illustrates how in vivo imaging allows the study of neuroimmune
interactions and axonal responses to injury and disease. At center is an image of a mouse superimposed with the fluorescence
image of a dissected central nervous system taken from a Thy1-XFP-transgenic mouse (modified from Misgeld and Kerschen-
steiner, 2006).
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after the initial injury (Canty et al., 2013b), similar to the spinal
dorsal column sensory axons described above (Lorenzana et al.,
2015). Therefore, in both the spinal cord and the brain, in vivo
imaging is revealing fundamental properties of axonal responses
to a minimal injury. In addition, the development of capabilities
to correlate in vivo imaging and electron microscopy allows for
ultrastructural examination of optically imaged cellular struc-
tures such as axonal boutons (AllegraMascaro et al., 2013; Canty
et al., 2013b) and end bulbs after CNS axon injury (Bishop et al.,
2011).
In vivo imaging reveals reversible axon damage in clinically
relevant models
Kerschensteiner and Misgeld and their teams have conducted
extensive in vivo imaging studies in animal models of CNS injury
and disease. Here, we discuss two studies that collectively illustrate a
potentially very important avenue for therapeutic development: to
rescue axons that are compromised but not yet fully degenerated
(presented by T. Misgeld, 2017 SfNMini-Symposium). In the first
study, Williams et al. (2014) used two-photon in vivo imaging to
follow many superficially located spinal axons after a spinal cord
contusion injury. They found that some axons became swollen in
their morphology. Some of these swollen axons went on to be-
come broken and degenerated; others recovered, meaning that
they returned to a more healthy-looking morphology. These re-
covered axons appeared to sustain and maintain integrity long
term (i.e., at least days) after injury. This recoverable state of
swollen axons lasts for hours and the fate of the axon depends on
intra-axonal calcium such that sustained intra-axonal calcium
elevations were associated with axonal degeneration, whereas re-
turn of the calcium level to baseline was associated with axonal
recovery. Removal of extracellular calcium with a Ca2 chelator
or pharmacologically inhibiting calpain, a calcium-dependent
protease, blocks axon degeneration. This study illustrates that
axonal rescue, for example, by manipulating intra-axonal cal-
cium, could be a promising strategy to preserve what is left in
connectivity and function following a clinically relevantmodel of
spinal cord injury.
In the other study, Nikic´ et al. (2011) discovered a reversible
form of axonal damage in an experimental autoimmune enceph-
alomyelitis (EAE)model ofmultiple sclerosis, which is analogous
to that in the spinal cord contusion injurymodel discussed above
(Williams et al., 2014). In a well characterized myelin oligoden-
drocyte glycoprotein-induced spinal EAE model, Nikic´ et al.
(2011) identified a state of axonal damage with focal swellings
that they termed focal axonal degeneration (FAD). Like the swol-
len axons after spinal cord contusion injury (Williams et al.,
2014), these swollen axons could become fully fragmented and
degenerated, but could also recover to healthy-looking axons
(Nikic´ et al., 2011). The swollen axons in the EAEmodel last days
instead of hours in the case of the contusion injury. Surprisingly,
early stages of swollen axons could be observed without apparent
myelin damage, indicating that axonal damage may precede
myelin lesion in EAE. Additional experiments implicated the in-
volvement of reactive oxygen and nitrogen species in FAD, as
pharmacologically suppressing the reactive species with scaven-
gers reduced axonal fragmentation (Nikic´ et al., 2011). Further,
this study, together with work from Sadeghian et al. (2016), re-
vealed mitochondrial damage as an early characteristic of axon
damage in the inflamed spinal cord. This subcellular pathology
was accompanied by loss of axonal transport of mitochondria
and other organelles (Sorbara et al., 2014; Sadeghian et al., 2016).
Therefore, just as with traumatic lesions, inflammatory diseases
of the CNS also lead to a reversible state of axonal damage with a
characteristic subcellular signature that can be rescuedwith phar-
macological manipulations. Together, these studies point to the
reversibility of axonal damage as a potential target to support
therapeutically after CNS injury and disease (Nikic´ et al., 2011;
Williams et al., 2014).
In vivo imaging of substantial regrowth of serotonergic axons
after brain damage
In general, axons do not regenerate to a significant extent after
injury in the CNS (Chew et al., 2012; Lu et al., 2014). However,
there have been suggestions from studies in both injured brain
and spinal cord (with or without a graft) that axons of serotoner-
gic neurons might have an atypical capacity for regrowth (Lee et
al., 2010; Alilain et al., 2011; Hawthorne et al., 2011; Kanno et al.,
2014). It has been known for quite some time that, after a lesion of
serotonergic axons in the rodent neocortex with a high dose of
amphetamine, there is a gradual reappearance of serotonin (or
5-HT) immunoreactive axons overmanymonths (Molliver et al.,
1990; Mamounas et al., 2000). Although suggestive, these fixed-
tissue amphetamine studies were inconclusive: it was not possible
to distinguish long-distance regrowth from local sprouting of
surviving axons, nor was it possible to rule out the scenario that
intact 5-HT axons were merely depleted of serotonin by amphet-
amine treatment and then slowly refilled. To disambiguate the
results from fixed-tissue studies, Jin et al. (2016) performed in
vivo two-photon time-lapse imaging of serotonergic axons over
many months after damage (presented by D. Linden, 2017 SfN
Mini-Symposium).
Using adult serotonin transporter-EGFPBAC transgenicmice
(Gong et al., 2003), Jin et al. (2016) found that serotonin axons
undergo widespread long-distance retrograde degeneration after
amphetamine treatment and that the subsequent slow recovery
of axonal density is dominated by long-distance regrowth with
little contribution from local sprouting. The new, regrowing
axons largely recapitulate the morphology (varicosity density,
tortuosity), neighbor relations, and layer-specific distribution of
prelesion axons. Unlike regrowing axons in the peripheral ner-
vous system (Scheib and Ho¨ke, 2013), new serotonin axons do
not follow the pathways left by degenerated axons. The new axons
have normal varicosity density, longevity, and trajectories. They
have the capacity to release serotonin, as measured by fast-scanning
voltammetry, and their regeneration is correlated with recovery in
behavioral tests. Furthermore, Jin et al. (2016) found that a stab
injury that transects serotonin axons in the neocortex is followed
by local regression of cut serotonin axons and by regrowth from
the cut ends that can project across the glial scar which forms in
the stab rift zone. Therefore, serotonin axons in the brain have an
unusual capacity to regrow (Kajstura et al., 2017) and this re-
growth is functional and approximates the prelesion state.
There are many important questions raised by these findings.
For instance, what are themolecular specializations that distinguish
serotonin axons from other CNS axons in their regenerative abili-
ties? In addition, are all raphe serotonin neurons competent to
regrow their axons or is this ability restricted to a particular ana-
tomical or functional subset, for example, serotonin neurons that
derive from embryonic rhombomere 1 (Jensen et al., 2008) or
serotonin neurons that corelease glutamate, as was the case for
retinal ganglion cells (Duan et al., 2015)?
In vivo imaging of retinal axons and target neurons
The optic nerve, the nerve bundle connecting the retina to the
brain, comprises the axons of retinal ganglion cells which contain
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all the visual information that is available for object recognition.
Restoring vision after optic nerve injuries such as brain trauma or
glaucoma requires that the retinal axons regenerate, reach their
appropriate brain targets, form functional synapses, and transmit
information that supports a dynamic and detailed representation
of the world. Although the mammalian optic nerve does not
regenerate naturally, recent advances have been able to promote
its regrowth over long distances, with some axons reaching nor-
mal brain targets and forming functional synapses by providing
specific molecular therapies or selectively enhancing neural ac-
tivity (Leaver et al., 2006; Moore et al., 2009; Sun et al., 2011; de
Lima et al., 2012; Bei et al., 2016; Lim et al., 2016). Analogous to in
vivo imaging paradigms described above for the spinal cord, in
vivo imaging of the optic nerve in the proximity of nerve crush
site close to the eye in anesthetized rodents providedmechanistic
link between intra-axonal calcium, autophagy, and axonal de-
generation (Kno¨ferle et al., 2010; Koch et al., 2011).
One emerging challenge will be a direct assessment of the
degree to which the visual representations of normal optic nerve
inputs to brain targets is recapitulated after regeneration. Whether re-
tinotopic map organization and visual tuning can be recovered
after regeneration of a fraction of axons in the optic tract is not
clear. Specific types of RGCs that show higher capabilities of re-
generation may be overrepresented (Duan et al., 2015; Norswor-
thy et al., 2017). Visualization of regenerating RGC axons would
permit discernment of how specific visual pathways or RGC sub-
types contribute to functional regeneration. However, it has been
difficult to measure structural changes and neural activity within
RGCs and their target neurons in the intact visual system of
awake animals.
M. Andermann and C. Chen and their colleagues have collab-
orated to develop in vivo methods that could, in future, allow
monitoring of the natural progression of regenerating optic nerve
and investigation of functional recovery in target areas such as the
dorsal lateral geniculate nucleus (dLGN), a central relay station in
the image formation pathway. Specifically, with the development
of in vivo two-photon fluorescence imaging in dLGN of awake,
head-fixed mice, Liang et al. could visualize the retinogeniculate
synapse from the level of individual synaptic boutons to the level
of large populations of cell bodies, and acrossmultiple timescales,
from milliseconds associated with electrical signaling to months
over which plastic changes supporting functional regeneration
occur (presented by L. Liang, 2017 SfN Mini-Symposium).
Chronic visualization of regenerating RGC axons could help
us to understand the detailed dynamics that occur during rewir-
ing. During normal development, axons undergo an intricate
sequence including axon outgrowth, initial connections with tar-
get neurons, followed by refinement of axonal branches and bou-
tons (Hong and Chen, 2011). Are these processes also occurring
in regenerating axons? By comparing the dynamics of regenerat-
ing axons with the knowledge of normal RGC development and
by comparing the behavior across axon growth induced through
differentmolecular or activity models, it may be possible to iden-
tify roadblocks to axon regeneration and important attributes of
each regeneration therapy. Moreover, chronic imaging will en-
able the evaluation of the degree of plasticity or stability of newly
formed connections.
In addition, by imaging activity in large populations of regen-
erating axons and of second-order neurons in vivo, the above
methodologies will allow assessment of the quality and quantity
of visual information restoration in the target brain circuit. Liang
et al. have begun to examine the neural activity transmitted in
RGC axons by imaging calcium activity in the optic nerve and
their terminals in the dLGN (Liang et al., 2017 SfN Mini-
Symposium). Although RGCs are composed of at least 30 dis-
tinct types, they can be well characterized by a few parameters:
spatial receptive field preferences, orientation/direction selectiv-
ity, sensitivity to luminance changes, and spatiotemporal frequency
preference (Farrow and Masland, 2011; Dhande et al., 2015; Sanes
andMasland, 2015). Their studies of RGC axons from healthymice
reveal exquisite functional organization among axons carrying in-
formation regardingdifferent visual features. These findings serve as
a baseline to assess, in future, whether retinotopicmap organization
andvisual tuning is restored inanorderlymannerafter regeneration.
In vivo imaging of microglia and neurovascular unit in CNS
disease and injury
The ability to capture dynamic cellular interactions is especially
warranted for research of neurological disorders typified by im-
mune activation, vascular alterations, and neuronal dysfunction
including Alzheimer’s disease (AD) (Burgold et al., 2011; Sagare
et al., 2013), multiple sclerosis (MS) (Davalos et al., 2012), and
stroke (Lam et al., 2010; Knowland et al., 2014; Balbi et al., 2017).
These disorders share a common hallmark of microglial activa-
tion and blood–brain barrier (BBB) disruption (Kwon and Pri-
neas, 1994; Tomimoto et al., 1996; Cortes-Canteli et al., 2015).
However, the sequence of events linking vascular changes and
immune activation remain poorly understood.
Implementation of in vivo imaging techniques at the neuro-
vascular interface has shed light onto the sequence of events and
the causal relationships linking vascular, immune, and neuronal
dysfunction in neurological diseases (Merlini et al., 2012;
Akassoglou et al., 2016) (presented by K. Akassoglou, 2017
SfN Mini-Symposium). Development of methodologies to im-
age simultaneously the vasculature with immune cells, glia, and
neurons, not only in the brain but also the spinal cord, has been
instrumental in understanding how changes in BBB permeability
correlate with the development of neuroinflammation and neu-
rologic diseases (Davalos et al., 2008; Davalos and Akassoglou,
2012b; Davalos et al., 2012; Merlini et al., 2012; Akassoglou et al.,
2016). Coregistration of in vivo two-photon imaging data with
correlative light-electronmicroscopy allowed unique insight into
the cellular and molecular mechanisms identifying causal rela-
tionships among blood proteins, microglial activation, and
axonal damage (Davalos et al., 2012). Development of a stable
optical window in the mouse skull allowed repetitive imaging of
microglia without causing brain inflammation (Drew et al.,
2010).Molecular probes to detect coagulation activity in the CNS
further provided tools for functional analysis of BBB disruption
and neurovascular alterations (Davalos et al., 2014). These com-
plementary tools enabled detailed image acquisition in vivo
within a relatively small field of view and imaging of large tissue
volumes ex vivo to reveal the distribution and scale of neuroin-
flammatory and neurodegenerative pathologies.
Studies using these tools to image the neurovascular interface
revealed unanticipated mechanisms for the development of neu-
roinflammatory disease. They demonstrated perivascular micro-
glia clustering at sites of BBB breakdown even before the onset of
neurological symptoms in themurineMSmodel EAE (Davalos et
al., 2012). Remarkably, microglial clustering was associated with
BBB leakage and deposition of the blood coagulation factor fi-
brinogen in the CNS. Live imaging of BBB disruption identified
focal extravasation of fibrinogen at sites of microglia clustering
and axonal damage. Time-lapse imaging in the mouse cortex
revealed rapid microglial responses to fibrinogen within minutes
that were sustained for several hours after injection (Davalos et
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al., 2012). Imaging using a thrombin molecular probe revealed
early increase of coagulation activity as one of the first signs in
EAE correlating with microglia activation and fibrin deposition,
but preceding demyelination (Davalos et al., 2014). Pharmaco-
logic depletion of fibrinogen or genetic disruption of the interac-
tion of fibrinogen with its CD11b/CD18 integrin receptor on
microglia reduced perivascular microglial clustering, neurologi-
cal signs, inflammatory responses, demyelination, and axonal
damage in EAE (Adams et al., 2007; Davalos et al., 2012).
Studying the sequence of events in neuroinflammatory dis-
ease by in vivo two-photonmicroscopy led to the identification of
BBB leakage and fibrin deposition as an early event preceding
microglial activation and demyelination. To test whether fibrin-
ogen was sufficient to induce these pathologies, fibrinogen was
stereotactically injected in the healthy CNS. Fibrinogen injection
in the corpus callosum stimulated macrophage recruitment, an-
tigen presentation, and activation of myelin antigen-specific Th1
cells leading to demyelination (Ryu et al., 2015). Fibrinogen-
induced encephalomyelitis could represent a novel experimental
setting for the study of vascular-driven, innate-immune medi-
ated neuroinflammation. Together, these studies highlight how
integration of in vivo imaging of the neurovascular interface may
reveal the sequence of events that leads to neurologic impair-
ment. Therefore, in vivo imaging is critical for the identification
of molecular pathways apical to disease pathogenesis and priori-
tization of further testing of their potential causal role for im-
mune and neurodegenerative mechanisms in the CNS. Using in
vivo imaging in animal models of neuroimmunology and neuro-
vascular dysfunction provides invaluable insight for the identifi-
cation of molecular targets that could be instrumental for the
development of novel therapeutic strategies, imaging probes, an-
imal models, and biomarkers for disease onset and progression
(Adams et al., 2007; Davalos and Akassoglou, 2012a; Davalos et
al., 2012; Bardehle et al., 2015; Ryu et al., 2015).
In vivo structural and functional imaging of transplanted
human induced pluripotent stem cell (iPSC)-derived neurons
In vivo optical imaging has revolutionized the study of synaptic
connectivity in cortical circuits, providing invaluable insights
into the role of synaptic rewiring in learning and memory (Holt-
maat and Caroni, 2016), aging (Grillo et al., 2013; Mostany et al.,
2013), and after injury (Allegra Mascaro et al., 2013; Canty
et al., 2013a, b) and disease (Cruz-Martín et al., 2010; Murmu et
al., 2013; Holtmaat and Caroni, 2016; Jackson et al., 2017). Many
fundamental questions regarding the biology of neural connec-
tivity have, until recently, been restricted to nonhuman models.
For example, it is not known whether and how human neurons
undergo synaptic rewiring in mature functional networks.
Equally unclear is how to best model the many human diseases
affecting synaptic connectivity, which include neurodevelop-
mental, psychiatric, and neurodegenerative diseases. In vivo op-
tical imaging of human-derived neurons is likely to play a pivotal
role in addressing these outstanding issues.
The in vitro generation of neurons differentiated from human
embryonic stem cells (ESCs) or iPSCs has emerged as a promising
tool with which to model the assembly of synaptic networks in
human brain development and diseases (Brennand et al., 2011;
Shcheglovitov et al., 2013;Wen et al., 2014). However, cultures of
ESC/iPSC-derived neurons, including cerebral organoids (Lan-
caster et al., 2013), lack vasculature and other key regulatory
signals and are therefore limited by short-term survival and in-
complete neuronal and synaptic maturation (Kim et al., 2011;
Thompson and Bjo¨rklund, 2015; Korecka et al., 2016). The trans-
plantation of human ESC/iPSC-derived neurons in the CNS of
rodents (also called chimeric human-rodent models) enhances
the survival and functionalmaturation of humanneurons (Espuny-
Camacho et al., 2013; Korecka et al., 2016; Niclis et al., 2017) and
substantial efforts are under way to fully elucidate whether and how
humanESC/iPSC-derivedneuronscan formsynapses and function-
ally integrate into the host neural circuitry. Twomajor prospects of
suchhumanizedrodent systemsare the improvementof cell replace-
ment therapy, for example, for stroke or brain injury, and more
accuratediseasemodeling thanpossiblewith current animal studies.
Although transplanted human PSC-derived neurons could
promote the functional recovery of damaged circuits through
variousmechanisms, including neuroprotection and stimulation
of host plasticity, several groups have investigated host-to-graft
functional connectivity through different strategies (Lindvall and
Kokaia, 2010; Lu et al., 2012; Byers et al., 2015; Thompson and
Bjo¨rklund, 2015). In a recent study, mouse embryonic neurons
were transplanted in the primary visual cortex of adult mice after
selective ablation of neurons in the same area (Falkner et al.,
2016). As shown previously (Michelsen et al., 2015), transplanted
neurons extended axons and received input fromhost neurons in
a target-specific manner. More importantly, by labeling the trans-
planted neurons with a genetically encoded calcium indicator and
performing in vivo imagingof stimulus-evoked responses, Falkner et
al. (2016)demonstrated that transplantedneurons respond to visual
stimuli in a manner indistinguishable from the host neurons, indi-
cating full integration within the host visual circuitry. However,
whether transplanted human ESC/iPSC-derived neurons have sim-
ilar dynamics of integration as transplanted embryonic neurons and
their mechanisms of integration remain unknown.
Interestingly, human iPSC-derived neurons transplanted in
the cortex of adult rats after distal middle cerebral artery occlu-
sion receive functional synaptic input from the host, as evidenced
by the presence of optogenetic and sensory stimulation-elicited
electrophysiological responses in the transplanted human neu-
rons (Tornero et al., 2017). In collaborationwithDr. Rick Livesey
(University of Cambridge, Cambridge, UK), Real and De Paola
(presented by V. De Paola, 2017 SfN Mini-Symposium) have
recently used longitudinal structural and functionalmultiphoton
imaging correlated with electron microscopy, combined with ra-
bies tracing, electrophysiology, andmolecular analyses tocharacter-
ize thedynamicsof transplantedhumanneurons forperiodsofup to
6 months. They show that transplanted human iPSC-derived neu-
rons of cortical identity form an interconnected circuit that receives
input from the host and undergoes functional synaptic rewiring.
Animal models of complex neurological diseases often do not
recapitulate the full extent of human phenotypes. The generation
of chimeric human–rodentmodels of neurological diseases is thus a
step forward,providingavaluable tool to investigatehuman-specific
phenotypes and disease mechanisms. A possible approach is to
transplant human ESC/iPSC-derived neurons from healthy indi-
viduals into animalmodels of disease. In a recent study, the trans-
plantation of healthy human ESC-derived neurons in a well
characterized mouse model of AD led to the development of AD
pathology in the human graft, including neuronal loss and the
appearance of pathological tau species, features not observed in
the host brain (Espuny-Camacho et al., 2017). An alternative
approach is the use of iPSC-derived neurons from patients with
specific neurological disorders, which provides insights into the
cell-autonomous factors contributing to disease phenotypes.
This approach is especially relevant to uncover neuronal matu-
ration defects as well as synaptic and neural circuitry dysfunction.
In this context, the use of in vivo synaptic and calcium imaging
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can elucidate cellular and network connectivity phenotypes,
helping us to understand the mechanisms underlying complex
human brain diseases in ways not previously possible. Using this
new system, De Paola and colleagues were able to show that neu-
rons from patients with Down’s syndrome fail to synchronize
network activity in vivo (presented by V. De Paola, 2017 SfN
Mini-Symposium).
Concluding remarks
In conclusion, as discussed here and at the 2017 SfN Mini-
Symposium, in vivo optical imaging has revealed fundamental
new insights on neuronal, glial, immune, vascular, and other
cellular responses to injury and disease in the mammalian CNS.
Just as 3D imaging of cleared tissue blocks addresses the spatial
complexity of the CNS (Chung et al., 2013), in vivo time-lapse
imaging tackles the temporal complexity. As with many other
areas in modern biology, we anticipate that technological ad-
vances will continue to serve as a driver for research progress, in
particularly where in vivo imaging intersects with other emerging
tools and technologies. Methods to facilitate repetitive in vivo
imaging across chronic time points (Drew et al., 2010; Farrar et
al., 2012; Fenrich et al., 2012), to image freely behaving mice
(Sekiguchi et al., 2016), and to image more deeply into the brain
(Ouzounov et al., 2017) are opening new frontiers of investiga-
tion. The availability of genetically encoded calcium and voltage
indicators (Lin and Schnitzer, 2016) allows for in vivo imaging of
neuronal activity; monitoring activity in single axons, however,
still remains an unmet challenge. New biosensors that monitor
metabolic parameters in neurons (Breckwoldt et al., 2014;
Ma¨chler et al., 2016; Trevisiol et al., 2017) will add further func-
tional dimensions to in vivo imaging. By integrating structural
and functional investigation in conjunction with methods to
monitor and manipulate neuronal activity (Kim et al., 2017) and
glial-neuron interatctions (Akassoglou et al., 2016), in vivo opti-
cal imaging will continue to enable new discoveries. Molecular
information revealed by multiomics approaches can be used for
the discovery and generation of novel molecular probes to detect
neuronal dysfunction, immune cell activation, and vascular ab-
normalities. These approaches have the potential to uncover new
avenues for therapeutic intervention in neurological diseases.
The latter is especially important given the gap between suc-
cessful drug discovery for CNS diseases and breakthroughs in the
discovery of mechanisms underlying disease pathogenesis. In
vivo optical imaging is ideally positioned to bridge this transla-
tional gap. First, in vivo two-photon imaging allows the study of
the sequence of events that lead to neurological disease, thus
revealing the early triggers and apicalmechanisms responsible for
disease pathogenesis. Identifying how disease starts is critical for
drug discovery because it allows the prioritization of drug targets.
Second, the versatility of in vivo two-photon imaging in bringing
to light various acute and chronic (patho)physiological phenom-
ena allows direct comparisons with findings from widely used
clinical imaging modalities such as functional magnetic reso-
nance imaging (fMRI),magnetic resonance spectroscopy (MRS),
and positron-emission tomography. An example of the strength
of such interchangeable, translational imaging studies is longitu-
dinal in vivo two-photon imaging of altered cerebral blood flow
and brain metabolism at early and late disease stages in rodent
models of neurological disease (San Martín et al., 2014; Stuntz et
al., 2017). The results of these can provide unprecedented, high-
resolution cellular insight into the mechanisms underlying simi-
lar changes in humans as measured by fMRI and MRS (Borsook
et al., 2006; Modrego et al., 2011). Finally, in vivo two-photon
imaging can be used to develop rapid pharmacodynamicsmodels
to accelerate drug discovery. For example, drug delivery through
a thinned skull and study of microglia responses using in vivo
two-photon imaging allows assessment of drug compounds
within 24 h after traumatic brain injury (Roth et al., 2014). There-
fore, in vivo optical imaging can critically contribute to transla-
tional efforts to combat neurological disease by identifying the
sequence of events that triggers and propagates CNS disease, fa-
cilitating the development of molecular probes and accelerating
drug discovery.
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